NASDAQ: ALMS - Alumis Inc.

六个月盈利: -47.19%
股息率: 0.00%
部门: Healthcare

促销时间表 Alumis Inc.

先进的时间表 简单图表
Financial Markets by TradingView

关于公司 Alumis Inc.

Alumis Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of medicines for autoimmune disorders. It develops ESK-001, an allosteric tyrosine kinase 2 (TYK2) inhibitor for the treatment of plaque psoriasis, systemic lupus erythematosus, and non-infectious uveitis; and A-005, a central nervous system-penetrant allosteric TYK2 inhibitor for neuroinflammatory and neurodegenerative diseases. The company was formerly known as Esker Therapeutics, Inc. and changed its name to Alumis Inc. in January 2022.

更多详情
The company was incorporated in 2021 and is headquartered in South San Francisco, California.
添加到比较列表
添加到观察列表
添加到投资组合
添加价格通知

IPO date 2024-06-28
Industry Biotechnology
Sector Health Care
Валюта usd
Валюта отчета usd
Сайт https://www.alumis.com
Цена ао 4.92
每日价格变化: +20% (4.7)
每周价格变化: +50.4% (3.75)
每月价格变化: +23.41% (4.57)
3个月内价格变化: -30.02% (8.06)
六个月内的价格变化: -47.19% (10.68)
年初以来价格变化: -30.02% (8.06)
所有参数

低估

姓名 意义 年级
P/S 0 0
P/BV 0 0
P/E 0 0
EV/EBITDA 0.0862 10
全部的: 3.75

效率

姓名 意义 年级
ROA, % -172.96 0
ROE, % -429.22 0
全部的: 0

股息

姓名 意义 年级
Div yield, % 0 0
DSI 0 0
全部的: 0

责任

姓名 意义 年级
Debt/EBITDA -0.2077 10
全部的: 10

成长冲动

姓名 意义 年级
盈利能力 Revenue, % 0 0
盈利能力 Ebitda, % 38.11 5
盈利能力 EPS, % -79.97 0
全部的: 2.8
更多详情

ETF分享, %本年盈利能力, %股息, %
iShares Micro-Cap ETF 0.03459 17.09 1.54048
iShares Russell 2000 Growth ETF 0.00556 38.04 0.6026
0.0227.571.07



导师 职称 支付 出生年份
Mr. Martin Babler Ph.D. President, CEO & Chairman 1965 (60 年)
Dr. David M. Goldstein Ph.D. Chief Scientific Officer 1966 (59 年)
Mr. Roy C. Hardiman J.D. Chief Business & Legal Officer 1960 (65 年)
Mr. John R. Schroer C.F.A. Chief Financial Officer 1965 (60 年)
Mr. Derrick Richardson Senior VP and Head of People & Culture 1970 (55 年)
Dr. Kenneth A. Brameld Ph.D. Head of Discovery & Esker Fellow 1973 (52 年)
Ms. Claire Langrish Ph.D. Senior VP & Head of Immunology and Translational Science
Mr. Philip Nunn Ph.D. Senior VP of Pharmacology & Project Team Leader
Dr. Jorn Drappa M.D., Ph.D. Chief Medical Officer & Head of Research and Development 1965 (60 年)
Dr. Roman G. Rubio M.D. Senior VP & Head of Clinical Development & Translational Medicine 1971 (54 年)

地址: United States, South San Francisco, 280 East Grand Avenue - 在 Google 地图中打开, 打开 Yandex 地图
网站: https://www.alumis.com